Related Experiment Video
Updated: Jul 4, 2025
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Disparities in healthcare access experienced by Hispanic chronic kidney disease patients: a cross-sectional analysis
Sadia Anjum Ashrafi1, Rifat Binte Alam1, Alicia Kraay1
1Department of Kinesiology and Community Health, University of Illinois Urbana-Champaign, Champaign, IL, USA.
Insights
Hispanic individuals with chronic kidney disease (CKD) face significant healthcare access barriers, including higher rates of being uninsured and lacking a regular doctor. Addressing these disparities is crucial for improving kidney health equity.
Area of Science:
- Public Health
- Nephrology
- Health Disparities
Background:
- Chronic kidney disease (CKD) is a significant public health issue.
- Hispanics are disproportionately affected by CKD.
- Improving healthcare access for Hispanic CKD patients is essential to reduce disease burden.
Purpose of the Study:
- To assess healthcare access disparities in Hispanic CKD patients compared to White patients.
- To identify specific areas of healthcare access where disparities exist.
Main Methods:
- Analysis of three National Health and Nutrition Examination Survey (NHANES) datasets (2013-2018).
- Examined insurance status, routine healthcare place, and past year health visits.
- Utilized chi-square tests and weighted multivariate logistic regressions, adjusted for demographics and CKD stage.
Main Results:
- Hispanic CKD patients were more likely to be uninsured (OR: 2.52) compared to White patients.
- Hispanic CKD patients had reduced access to a routine place for healthcare (OR: 1.68).
- No significant difference was found in the number of healthcare visits in the past year between groups.
Conclusions:
- Hispanic CKD patients experience notable healthcare access disparities compared to White populations.
- Targeted programs and policies are needed to improve kidney health and promote equity for Hispanics.
- Addressing insurance and regular care access is critical for equitable CKD management.
Background:
Chronic kidney disease (CKD) is a public health concern, and the disease disproportionately affects Hispanics. Improved healthcare access for Hispanic CKD patients can reduce the disease burden. This study assesses the healthcare access disparities experienced by Hispanic CKD patients compared to Whites.
Methods:
We analyzed three National Health and Nutrition Examination Survey (NHANES) datasets for 2013-2014, 2015-2016, and 2017-2018. The primary predictor variable was race, and the outcome variable was three domains of healthcare access: insurance status, having any routine place for healthcare, and having any health visits in the past year. Chi-square tests and unadjusted and adjusted multivariate logistic regressions were conducted. The models were adjusted for age, education, income, and CKD stages and were weighted to account for the sampling strategy.
Results:
The sample size was 1864 CKD patients from three two-year cycles of NHANES datasets (2013-2014, 2015-2016, and 2017-2018). The final adjusted model found that Hispanic CKD patients were more likely to be uninsured (OR: 2.52, CI 1.66-3.83) and have no routine place for healthcare (OR: 1.68, CI 1.03-2.75) than White CKD patients, but did not have differences in healthcare visits in the past year.
Conclusions:
Hispanic CKD patients have limited healthcare access compared to White populations showing existing care access disparities experienced by them. Improved programs and policies are required to enhance kidney health among Hispanics and promote equity in CKD.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:07Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
01:20Comparing the Survival Analysis of Two or More Groups
01:22Heart Failure Drugs: Diuretics